MMED MiniMed

NASDAQ
$19.98

MiniMed (MMED) is expected to report earnings on December 1, 2026, before the market open. The consensus earnings estimate is $0.15 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.1% since its last earnings release on September 1, 2026.

MiniMed Missed Consensus Estimates, Raises Guidance
Tuesday, September 1, 2026 · 6:45 AM ET
Earnings Date
2nd Quarter, Oct 2026
Dec 1
Tuesday · 6:45 AM ET
Earnings Whisper
-
vs $0.15
Rev est $834.15M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $22.37

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About MiniMed

MiniMed is a global leader in insulin delivery, constantly advancing therapies that support people with diabetes in more than 80 countries.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Charts powered in part by Lightweight Charts™ by TradingView.